Excelra will provide absorption, distribution, metabolism, and excretion data, as well as binding assay datasets, from its database to Silexon. Gostar's database includes information encompassing more than 8 million compounds and 28 million structure activity relationship-associated data points.

Silexon uses real-world biological data and machine-learning capabilities to aid in drug design. Silexon will use Gostar for drug discovery and biopharmaceutical research. This collaboration has the potential to shorten the time to market for new lifesaving drugs, according to the firms.

No financial terms of the agreement were disclosed.

New machine-learning approach promises to speed drug design
A new approach to machine learning outperformed current machine-learning methods in drug design, demonstrating its potential in speeding up the drug discovery...

Excelra launches updated Gostar chemistry insights engine
Data science firm Excelra has released an updated version of its Gostar chemistry insights engine. The updated version includes a more advanced search...